Learning Center
Plans & pricing Sign in
Sign Out

2012 | | Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012

 announces, The Latest market research report is available in
its vast collection:

Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012

 You can also request for sample page of above mention reports on


Global Markets Direct’s pharmaceuticals report, “Idenix Pharmaceuticals, Inc. -
Product Pipeline Review - 2012” provides data on the Idenix Pharmaceuticals, Inc.’s
research and development focus. The report includes information on current
developmental pipeline, complete with latest updates, and features on discontinued
and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Idenix Pharmaceuticals, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Idenix
Pharmaceuticals, Inc. and industry-specific third party sources, put together by
Global Markets Direct’s team.


- Idenix Pharmaceuticals, Inc. - Brief Idenix Pharmaceuticals, Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Idenix Pharmaceuticals, Inc. human therapeutic
- Overview of pipeline therapeutics across various therapy areas.

Reasons to buy

- Evaluate Idenix Pharmaceuticals, Inc.’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of Idenix Pharmaceuticals, Inc. in its therapy areas of
- Identify new drug targets and therapeutic classes in the Idenix Pharmaceuticals,
Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in
those areas.

Table of contents:

List of Tables 5
List of Figures 5
Idenix Pharmaceuticals, Inc. Snapshot 6
Idenix Pharmaceuticals, Inc. Overview 6
Key Information 6
Key Facts 6
Idenix Pharmaceuticals, Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
Idenix Pharmaceuticals, Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Idenix Pharmaceuticals, Inc. – Pipeline Products Glance 12
Idenix Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Idenix Pharmaceuticals, Inc. – Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
Idenix Pharmaceuticals, Inc. – Drug Profiles 15
Additional Nucleotide Inhibitors 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
IDX-184 + IDX-719 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
IDX-19368 + Ribavirin 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
IDX077 18
Product Description 18
Mechanism of Action 18

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Product Pipeline Review – 2012 Pipeline
Review – 2012&PubId=&pagenum=1

HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012

Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012

IntelGenx Corp. – Product Pipeline Review – 2012

Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012

JADO Technologies GmbH – Product Pipeline Review – 2012
Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012

NeuroSearch A/S – Product Pipeline Review – 2012

NovaDel Pharma, Inc. – Product Pipeline Review – 2012

Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare and

For More details Plz do contact :

Aarkstore Enterprise




To top